MedPath

CPAP for Infantile Pompe Disease

Phase 4
Conditions
Pompe Disease
Registration Number
NCT02405624
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Patients with infantile onset Pompe disease will be trained with continuous positive airway pressure to see if hypernasality can be improved.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3
Inclusion Criteria
  1. confirm as Pompe disease
  2. Age 4 and can speak 2-words sentence by order
  3. mild to severe hypernasality
  4. have regular speech therapy for 8 weeks or longer
Exclusion Criteria

(1)hearing loss (2)congenital pharyngeal or laryngeal structure anomalies including cleft palate (3)cerebral palsy (4)recent otitis media effusion (5)very severe hypernasality (6)use non-invasive ventilator

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
decrease in hypernasality6 months

score hypernasality degree and compare

Secondary Outcome Measures
NameTimeMethod
increase in speech intelligibility6 months

score speech intelligibility degree and compare

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

National Taiwan University Hospital
🇨🇳Taipei, Taiwan
Yin-Hsiu Chien, MD, PhD
Contact
+886223123456
chienyh@ntu.edu.tw

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.